Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Cutaneous lupus erythematosus: update of therapeutic options part II.

Kuhn A, Ruland V, Bonsmann G.

J Am Acad Dermatol. 2011 Dec;65(6):e195-213. doi: 10.1016/j.jaad.2010.06.017. Epub 2010 Aug 30. Review.

PMID:
20800319
2.

[Systemic treatment of cutaneous lupus erythematosus].

Wenzel J, Bieber T, Uerlich M, Tüting T.

J Dtsch Dermatol Ges. 2003 Sep;1(9):694-704. Review. German.

PMID:
16285276
3.

S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).

Kuhn A, Aberer E, Bata-Csörgő Z, Caproni M, Dreher A, Frances C, Gläser R, Klötgen HW, Landmann A, Marinovic B, Nyberg F, Olteanu R, Ranki A, Szepietowski JC, Volc-Platzer B.

J Eur Acad Dermatol Venereol. 2017 Mar;31(3):389-404. doi: 10.1111/jdv.14053. Epub 2016 Dec 20.

PMID:
27859683
4.

Treatment of cutaneous lupus.

Chang AY, Werth VP.

Curr Rheumatol Rep. 2011 Aug;13(4):300-7. doi: 10.1007/s11926-011-0180-z. Review.

5.
6.

Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.

Cocito D, Grimaldi S, Paolasso I, Falcone Y, Antonini G, Benedetti L, Briani C, Fazio R, Jann S, Matà S, Sabatelli M, Nobile-Orazio E; Italian Network for CIDP Register.

Eur J Neurol. 2011 Dec;18(12):1417-21. doi: 10.1111/j.1468-1331.2011.03495.x. Epub 2011 Aug 5.

PMID:
21819489
7.

[Refractory subacute cutaneous lupus erythematosus treated with rituximab].

Cieza-Díaz DE, Avilés-Izquierdo JA, Ceballos-Rodríguez C, Suárez-Fernández R.

Actas Dermosifiliogr. 2012 Jul-Aug;103(6):555-7. doi: 10.1016/j.ad.2011.10.013. Epub 2012 Apr 5. Spanish. No abstract available.

PMID:
22482740
8.

Disease-modifying treatment in systemic sclerosis: current status.

Quillinan NP, Denton CP.

Curr Opin Rheumatol. 2009 Nov;21(6):636-41. doi: 10.1097/BOR.0b013e3283310d57. Review.

PMID:
19726995
9.

Treating immunobullous diseases: an update.

Reynaert S, Black MM.

Dermatol Nurs. 2004 Feb;16(1):29-34, 70. Review.

PMID:
15022502
10.

Update on the management of lupus nephritis: let the treatment fit the patient.

Bertsias G, Boumpas DT.

Nat Clin Pract Rheumatol. 2008 Sep;4(9):464-72. doi: 10.1038/ncprheum0896. Review.

PMID:
18756272
11.

Cutaneous lupus erythematosus: diagnosis and management.

Fabbri P, Cardinali C, Giomi B, Caproni M.

Am J Clin Dermatol. 2003;4(7):449-65. Review.

PMID:
12814335
12.

Cutaneous lupus erythematosus: update of therapeutic options part I.

Kuhn A, Ruland V, Bonsmann G.

J Am Acad Dermatol. 2011 Dec;65(6):e179-93. doi: 10.1016/j.jaad.2010.06.018. Epub 2010 Aug 23. Review.

PMID:
20739095
13.

How to treat refractory arthritis in lupus?

Artifoni M, Puéchal X.

Joint Bone Spine. 2012 Jul;79(4):347-50. doi: 10.1016/j.jbspin.2011.12.010. Epub 2012 Feb 14. Review.

PMID:
22341583
14.

Innovative management of lupus erythematosus.

Knott HM, Martínez JD.

Dermatol Clin. 2010 Jul;28(3):489-99. doi: 10.1016/j.det.2010.03.007.

PMID:
20510759
15.

The different faces of cutaneous lupus erythematosus.

Renner R, Sticherling M.

G Ital Dermatol Venereol. 2009 Apr;144(2):135-47. Review.

PMID:
19357621
16.

New treatment strategies for proliferative lupus nephritis: keep children in mind!

Ranchin B, Fargue S.

Lupus. 2007;16(8):684-91. Review.

PMID:
17711908
17.

Immunosuppressive therapy in children.

Prasad R, Singh UK, Mittal R, Mishra OP.

J Indian Med Assoc. 2011 Feb;109(2):101-2, 104-7. Review.

PMID:
21888174
18.

Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies.

Schiavo AL, Puca RV, Ruocco V, Ruocco E.

Clin Dermatol. 2010 May-Jun;28(3):337-43. doi: 10.1016/j.clindermatol.2009.06.018.

PMID:
20541689
19.

Recent news in the treatment of lupus nephritis.

Tesar V, Hruskova Z.

Minerva Med. 2012 Aug;103(4):235-51. Review.

PMID:
22805617
20.

Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients.

Wenzel J, Brähler S, Bauer R, Bieber T, Tüting T.

Br J Dermatol. 2005 Jul;153(1):157-62.

PMID:
16029342

Supplemental Content

Support Center